Fore Biotherapeutics at AACR 2027
Apr 2–7, 2027 Orlando, FL ~23k attendees Website
Fore Biotherapeutics at AACR 2027 in Orlando: Booth 2107.
| Organization | AACR 2027 Attendance |
|---|---|
Fore Biotherapeutics Philadelphia, PA | |
Clinical-stage company developing plixorafenib, a next-generation BRAF inhibitor that avoids paradoxical MAPK activation, in a phase 2 basket trial for BRAF-altered cancers. | Booth Exhibiting at Booth 2107 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Instantly find 20 buyers from Fore Biotherapeutics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the American Association for Cancer Research. Organization details are derived from AACR’s published exhibitor list. Submit a correction